| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Nabulsi Azmi is a Chief Operating Officer at Phathom Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 2 buys and 27 sells.
Estimated insider holdings value: $3.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 7,886 | $6.59 | $51,956.91 | -3.3% | -42.6% | +100.4% | |
| Dec 19, 2024 | PHAT Phathom Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 1,118 | $8.00 | $8,944.00 | -0.5% | -22.3% | +124.2% | |
| Jul 15, 2024 | PHAT Phathom Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 10,901 | $11.72 | $127,759.72 | -4.3% | +20.6% | -32.6% | |
| Apr 11, 2023 | PHAT Phathom Pharmaceuticals, Inc. | Chief Operating Officer | Buy | 10,000 | $8.26 | $82,600.00 | +11.2% | +69.8% | +43.4% | |
| May 16, 2022 | PHAT Phathom Pharmaceuticals, Inc. | Chief Operating Officer | Buy | 20,000 | $8.16 | $163,288.00 | +2.6% | +41.0% | +52.7% | |
| May 4, 2021 | PHAT Phathom Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 14,500 | $37.84 | $548,656.08 | -0.4% | -11.3% | -62.1% | |
| Apr 5, 2021 | PHAT Phathom Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 14,500 | $36.63 | $531,101.79 | -0.4% | -2.5% | -57.9% | |
| Mar 2, 2021 | PHAT Phathom Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 14,500 | $45.88 | $665,290.08 | -0.3% | - | - | |
| Feb 2, 2021 | PHAT Phathom Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 14,500 | $39.89 | $578,440.68 | -0.6% | - | - | |
| Dec 2, 2020 | PHAT Phathom Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 14,500 | $44.74 | $648,688.04 | -0.4% | - | - |